The US healthcare 3D printing market size is estimated to be USD 0.70 billion in 2026 and projects that the 3D printing market size will rise at a rate of 18.25% between 2026 and 2035 and at 2035 to USD 2.67 billion.
US Healthcare 3D Printing Market Revenue and Trends
The healthcare 3D printing market of the US offers additive manufacturing of patient specific medical devices, anatomic models, implants, prosthetics, surgical guides, bioprinted tissue, and regenerative scaffolds to hospitals, medical device firms, and research centers with the use of biocompatible polymers, metals, ceramics, and bioinks.
The US healthcare 3D printing market is rapidly developing, owing to the rising need for personalized medicine, escalation of orthopedic and dental pathology, emergence of preoperative planning appliances, expansion of bioprinting investigations, and progress of high-resolution multi-material printers, AI-optimized designs, and regulation-approved biocompatible substances in healthcare systems.
.png)
What are the Factors That Have a Significant Contribution to the Growth of the US healthcare 3D printing market?
The increased orthopedic/dental procedures, aging population needs, and focus on more accurate surgery to minimize complications have resulted in a surge in customized implants, prosthetics and models of surgery, and this is increasing the demand for healthcare products of 3D printing. With the increase in value based care and patient-centered solutions, an increasing number of providers and manufacturers will require additive technologies to achieve better outcomes, lead time reduction, and reduced costs in comparison with traditional manufacturing.
The advent of technology has also brought novel technologies such as AI-assisted optimization of designs, accelerated multi-jet fusion and SLA, improved bioinks in tissue engineering, and digital workflows with integrated workflows and imaging systems/PACS, which make it more accurate, quicker, and clinically integrated. Additional reasons are a rise in FDA clearance of 3D-printed devices, more reimbursements of patient-specific applications, strong investment in R&D by university and biotech companies, and government-sponsored innovation efforts and regenerative medicine partnerships.
Segment Insight
By Product Type
Medical implants and prosthetics, by far the biggest portion of the US healthcare 3D printing market through 2025, were led by high demand in the orthopedics, craniomaxillofacial, and dental sectors in the need to provide patient-specific replacement solutions to enhance fit, minimize the time required to perform surgery, and reduce complications, with further development of porous titanium structure, bioresorbable polymers, and hybrid metal-polymer implants being listed by many surgeons and implant manufacturers as having the best potential to make significant improvements to personalized reconstructive procedures.
By Distribution Channel
The biggest market share is between the direct sales to hospitals and medical and surgical centers as the key centers of procurement of on-demand 3D printing systems, materials, and services in preoperative models, custom implants, and point-of-care production. As these channels offer professional background on workflow integration, regulatory compliance, training surgeons, and prototyping with high speed in the clinical facilities, they have been favored channels of adoption of healthcare 3D printing technologies.
Report Scope
Feature of the Report | Details |
Market Size in 2026 | USD 0.70 billion |
Projected Market Size in 2035 | USD 2.67 billion |
Market Size in 2025 | USD 0.59 billion |
CAGR Growth Rate | 18.25% CAGR |
Base Year | 2025 |
Forecast Period | 2026-2035 |
Key Segment | By Component, Technology, Application, Material Type, End User and Region |
Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Recent Developments
In February 2025: Auxilium Biotechnologies showed improved microgravity onboard the International Space Station 3D bioprinting of implantable medical devices and demonstrated better structural accuracy of the layer, potentially applicable in complex tissue scaffolds and with regenerative medicine in the US healthcare system.
List of the prominent players in the US Healthcare 3D Printing Market:
Stratasys Ltd.
3D Systems Corporation
GE Additive (GE Healthcare)
Materialise NV
EnvisionTEC (ETEC)
Organovo Holdings, Inc.
CELLINK (BICO Group)
Formlabs Inc.
Renishaw plc
Stryker Corporation
Others
The US Healthcare 3D Printing Market is segmented as follows:
By Component
Systems (3D Printers)
Materials
o Metals & Alloys
o Polymers
o Ceramics
o Biomaterials
Services
Software
By Technology
Stereolithography (SLA)
Fused Deposition Modeling (FDM)
Selective Laser Sintering (SLS)
PolyJet
Direct Metal Laser Sintering (DMLS)
Electron Beam Melting (EBM)
Other Technologies
By Application
Prosthetics & Implants
Surgical Planning & Guides
Bioprinting & Tissue Engineering
Dental Applications
External Wearable Devices
Pharmaceutical/Drug Delivery
Other Applications
By Material Type
Metals
Polymers
Ceramics
Biomaterials
By End User
Hospitals & Surgical Centers
Medical Device Companies
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
